Findings

What do systematic reviews say?

6 questions · 6 findings · 2 reviews · Airways

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 1 · 16.7%Moderate 3 · 50%High 1 · 16.7%

Symptom score at 10 days. Measured on a 7‐point scale (0 to 6) ; lower score denotes fewer symptoms · acute asthma exacerbation

1 finding from 1 review

Antibiotics for exacerbations of asthma 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 2 participants
Moderate

Serious adverse events Duration 3 days to 3 weeks · acute asthma exacerbation

Antibiotics showed no clear difference in serious adverse events Duration 3 days to 3 weeks compared with placebo or usual care (low certainty).

1 finding from 1 review

Antibiotics for exacerbations of asthma 2018 · Cochrane Headline outcomes only
RD 0
3 studies · 502 participants
Low

Length of hospital stay · acute asthma exacerbation

1 finding from 1 review

Antibiotics for exacerbations of asthma 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Very low

PEFR (GIV) Duration 10 days · acute asthma exacerbation

1 finding from 1 review

Antibiotics for exacerbations of asthma 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 469 participants
Moderate

Length of stay (inpatients only) · exacerbations of COPD

1 finding from 1 review

Antibiotics for exacerbations of chronic obstructive pulmonary disease 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 300 participants
High

Duration of hospital stay (days) ‐ ICU patients · exacerbations of COPD

1 finding from 1 review

Antibiotics for exacerbations of chronic obstructive pulmonary disease 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 94 participants
Moderate